Results 21 to 30 of about 358,218 (312)

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. [PDF]

open access: yes, 2010
The main objectives of this study were to define the occurrence and levels of hepatitis B virus (HBV) DNA in asymptomatic HBV carriers, cirrhosis patients and hepatocellular carcinoma (HCC) cases from The Gambia, and to evaluate the risk for cirrhosis or
Whittle, H   +23 more
core   +1 more source

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club [PDF]

open access: yes, 2005
Sepsis is a systemic inflammatory response to the presence of infection, mediated via the production of many cytokines, including tumour necrosis factor alpha (TNF-alpha), interleukin (IL)-6, and IL-1, which cause changes in the circulation ...
Wong, F.   +23 more
core   +1 more source

Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models

open access: yesFrontiers in Physiology, 2021
Background: Liver cirrhosis is a relevant comorbidity with increasing prevalence. Postoperative decompensation and development of complications in patients with cirrhosis remains a frequent clinical problem.
Johannes Chang   +21 more
doaj   +1 more source

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis [PDF]

open access: yes, 1991
In 11 patients with decompensated cirrhosis and deteriorating renal function, the effect of the vasoconstrictor substance 8-ornithin vasopressin (ornipressin; POR 8; Sandoz, Basel, Switzerland) on renal function, hemodynamic parameters, and humoral ...
Reither, H.   +8 more
core   +1 more source

Albumin-bilirubin, Child-Pugh, and model for end-stage liver disease scores for the assessment of prognosis in cirrhotic patients

open access: yesThe Turkish Journal of Gastroenterology, 2017
Cite this article as: Zhu J, Guo X, Qi X. Albumin-bilirubin, Child-Pugh, and model for end-stage liver disease scores for the assessment of prognosis in cirrhotic patients. Turk J Gastroenterol 2017.
Jia Zhu, Xiaozhong Guo, Xingshun Qi
doaj   +1 more source

Cell Death and Liver Disease

open access: yesGut and Liver, 2020
Cell death is now reclassified into several types based on the mechanisms and morphologic phenotype. Understanding of such classifications offers insights into the pathogenesis of liver disease, as well as diagnostic or therapeutic implications ...
Satoka Aizawa   +2 more
doaj   +1 more source

Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. [PDF]

open access: yes, 1985
One hundred and eighty nine patients with primary biliary cirrhosis were entered into a double blind, placebo controlled randomised trial starting in January 1978 to assess the therapeutic value of d-penicillamine 1200 mg daily.
Tygstrup, Niels   +7 more
core   +1 more source

Liver cirrhosis [PDF]

open access: yesNursing Standard, 2008
Cirrhosis is defined as the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, which leads to portal hypertension and end-stage liver disease. Recent advances in the understanding of the natural history and pathophysiology of cirrhosis, and in treatment of its complications, have resulted ...
Detlef, Schuppan, Nezam H, Afdhal
openaire   +4 more sources

Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study

open access: yesGastroenterology Research and Practice, 2015
Background and Aims. A retrospective cross-sectional study was conducted to evaluate the role of hyaluronic acid (HA), laminin (LN), amino-terminal propeptide of type III procollagen (PIIINP), and collagen IV (CIV) in predicting the presence of ...
Xingshun Qi   +9 more
doaj   +1 more source

Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites [PDF]

open access: yes, 1993
Torasemide is a new loop diuretic with a longer half-life and longer action than furosemide in healthy subjects. In order to evaluate the pharmacodynamic effects, single oral doses of furosemide (80 mg) and torasemide (20 mg), which were equipotent in ...
Paumgartner, Gustav   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy